Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eight-week, Multi-centre, Dose-response, Double Blind, Placebo-controlled, Randomized, Parallel-group, Phase II Trial of SI000413 in Knee Osteoarthritis
KCT0000341Phase 2Recruiting
- Sponsor
- Dong-A Pharmaceutical
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SI000413 in knee osteoarthritis (OA), sponsored by Dong-A Pharmaceutical. Started Jan 2012; status: recruiting.
02
Drugs
SI000413
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on KCT0000341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000341.